• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素抵抗是2型糖尿病患者骨骼肌葡萄糖摄取的特征,但不是心脏葡萄糖摄取的特征。

Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.

作者信息

Utriainen T, Takala T, Luotolahti M, Rönnemaa T, Laine H, Ruotsalainen U, Haaparanta M, Nuutila P, Yki-Järvinen H

机构信息

Turku PET Centre, University of Turku, Finland.

出版信息

Diabetologia. 1998 May;41(5):555-9. doi: 10.1007/s001250050946.

DOI:10.1007/s001250050946
PMID:9628273
Abstract

Skeletal muscle insulin resistance and coronary heart disease (CHD) often precede non-insulin-dependent diabetes mellitus (NIDDM). A recent study showed the myocardium of patients with CHD to be insulin resistant, independent of blood flow. We determined whether myocardial insulin resistance is a feature of NIDDM patients with no CHD. Skeletal muscle and myocardial glucose uptake were determined in 10 patients with NIDDM and 9 age- and weight-matched normal men of similar age and body mass index men using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography under normoglycaemic hyperinsulinaemic conditions. Whole body glucose uptake, as determined by the euglycaemic clamp technique, was significantly lower in the patients with NIDDM (35+/-3 micromol/kg body weight min) than the normal subjects (45+/-3 micromol/kg body weight x min, p < 0.02). Insulin-stimulated femoral muscle glucose uptake was significantly lower in the patients with NIDDM (71+/-6 micromol/kg muscle x min) than in the normal subjects (96+/-5 micromol/kg muscle x min, p < 0.01). Whole body glucose uptake was correlated with femoral muscle glucose uptake in the entire group (r=0.76, p < 0.001), in patients with NIDDM and in normal subjects. Rates of insulin-stimulated myocardial glucose uptake were comparable between the patients with NIDDM (814+/-76 micromol/kg muscle min) and the normal subjects (731+/-63 micromol/kg muscle min, p > 0.4). Whole body or femoral muscle, and myocardial glucose uptake were not correlated in all subjects, patients with NIDDM or normal subjects. We conclude that insulin resistance of the myocardium is not a feature of uncomplicated NIDDM.

摘要

骨骼肌胰岛素抵抗和冠心病(CHD)往往先于非胰岛素依赖型糖尿病(NIDDM)出现。最近一项研究表明,冠心病患者的心肌存在胰岛素抵抗,且与血流无关。我们确定心肌胰岛素抵抗是否是非冠心病NIDDM患者的一个特征。在正常血糖高胰岛素血症条件下,使用[18F]-2-氟-2-脱氧-D-葡萄糖和正电子发射断层扫描技术,测定了10例NIDDM患者以及9名年龄和体重匹配、年龄和体重指数相近的正常男性的骨骼肌和心肌葡萄糖摄取情况。通过正常血糖钳夹技术测定的全身葡萄糖摄取量,NIDDM患者(35±3微摩尔/千克体重·分钟)显著低于正常受试者(45±3微摩尔/千克体重·分钟,p<0.02)。NIDDM患者胰岛素刺激的股四头肌葡萄糖摄取量(71±6微摩尔/千克肌肉·分钟)显著低于正常受试者(96±5微摩尔/千克肌肉·分钟,p<0.01)。在整个研究组、NIDDM患者和正常受试者中,全身葡萄糖摄取量与股四头肌葡萄糖摄取量相关(r = 0.76,p<0.001)。NIDDM患者(814±76微摩尔/千克肌肉·分钟)和正常受试者(731±63微摩尔/千克肌肉·分钟,p>0.4)胰岛素刺激的心肌葡萄糖摄取率相当。在所有受试者、NIDDM患者或正常受试者中,全身或股四头肌以及心肌葡萄糖摄取量均无相关性。我们得出结论,心肌胰岛素抵抗不是单纯NIDDM的特征。

相似文献

1
Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.胰岛素抵抗是2型糖尿病患者骨骼肌葡萄糖摄取的特征,但不是心脏葡萄糖摄取的特征。
Diabetologia. 1998 May;41(5):555-9. doi: 10.1007/s001250050946.
2
Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.冠心病患者的心肌和骨骼肌胰岛素抵抗。一项正电子发射断层扫描研究。
J Clin Invest. 1996 Nov 1;98(9):2094-9. doi: 10.1172/JCI119015.
3
Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.在非胰岛素依赖型糖尿病中,胰岛素对骨骼肌血流的刺激作用、其异质性和再分布完整,但对葡萄糖摄取的刺激作用则不然。
J Clin Invest. 1997 Aug 15;100(4):777-85. doi: 10.1172/JCI119591.
4
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.在肥胖状态下,增强内皮依赖性血流并不能改善骨骼肌对葡萄糖摄取的胰岛素抵抗。
J Clin Invest. 1998 Mar 1;101(5):1156-62. doi: 10.1172/JCI1065.
5
Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.运动员心脏和骨骼肌中胰岛素刺激的葡萄糖摄取存在不同变化。
J Clin Invest. 1994 May;93(5):2267-74. doi: 10.1172/JCI117226.
6
Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.胰岛素刺激的葡萄糖代谢改变状态下人体骨骼肌中己糖激酶、磷酸果糖激酶和糖原合酶的基因表达及活性研究。
Dan Med Bull. 1999 Feb;46(1):13-34.
7
Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.非胰岛素依赖型糖尿病和高血压患者的器官特异性胰岛素抵抗。
J Nucl Med. 1998 May;39(5):884-9.
8
Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men.肥胖男性中胰岛素和运动刺激的骨骼肌血流及葡萄糖摄取
Obes Res. 2003 Feb;11(2):257-65. doi: 10.1038/oby.2003.39.
9
Myocardial insulin resistance in patients with syndrome X.X综合征患者的心肌胰岛素抵抗
J Clin Invest. 1997 Oct 15;100(8):1919-27. doi: 10.1172/JCI119722.
10
Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.非胰岛素依赖型糖尿病(NIDDM)患者及肥胖者成纤维细胞和骨骼肌中葡萄糖转运异常及葡萄糖转运蛋白1(GLUT1)细胞表面含量变化
Diabetologia. 1997 Apr;40(4):421-9. doi: 10.1007/s001250050696.

引用本文的文献

1
Simultaneous in vivo multi-organ fluxomics reveals divergent metabolic adaptations in liver, heart, and skeletal muscle during obesity.同时进行的体内多器官通量组学揭示肥胖期间肝脏、心脏和骨骼肌中不同的代谢适应性变化。
Cell Rep. 2025 May 27;44(5):115591. doi: 10.1016/j.celrep.2025.115591. Epub 2025 Apr 16.
2
Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy.心脏中丙酮酸脱氢酶的抑制作为糖尿病心肌病发展的起始事件。
Antioxidants (Basel). 2023 Mar 20;12(3):756. doi: 10.3390/antiox12030756.
3
Oligonucleotide Therapeutics for Age-Related Musculoskeletal Disorders: Successes and Challenges.
用于治疗与年龄相关的肌肉骨骼疾病的寡核苷酸疗法:成功与挑战
Pharmaceutics. 2023 Jan 10;15(1):237. doi: 10.3390/pharmaceutics15010237.
4
Regenerating islet-derived protein 3α: A promising therapy for diabetes. Preliminary data in rodents and in humans.再生胰岛衍生蛋白3α:一种有前景的糖尿病治疗方法。啮齿动物和人类的初步数据。
Heliyon. 2022 Jul 16;8(7):e09944. doi: 10.1016/j.heliyon.2022.e09944. eCollection 2022 Jul.
5
Metabolic Syndrome Is Associated With Impaired Insulin-Stimulated Myocardial Glucose Metabolic Rate in Individuals With Type 2 Diabetes: A Cardiac Dynamic F-FDG-PET Study.代谢综合征与2型糖尿病患者胰岛素刺激的心肌葡萄糖代谢率受损相关:一项心脏动态F-FDG-PET研究。
Front Cardiovasc Med. 2022 Jun 29;9:924787. doi: 10.3389/fcvm.2022.924787. eCollection 2022.
6
Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review).2 系列前列腺素在 2 型糖尿病和非酒精性脂肪性肝病发病机制中的作用(综述)。
Int J Mol Med. 2021 Jun;47(6). doi: 10.3892/ijmm.2021.4947. Epub 2021 Apr 28.
7
The Role of Isoflavones in Type 2 Diabetes Prevention and Treatment-A Narrative Review.异黄酮在 2 型糖尿病预防和治疗中的作用——叙述性综述。
Int J Mol Sci. 2020 Dec 28;22(1):218. doi: 10.3390/ijms22010218.
8
Anti-Inflammatory Strategies Targeting Metaflammation in Type 2 Diabetes.针对 2 型糖尿病代谢炎症的抗炎策略。
Molecules. 2020 May 9;25(9):2224. doi: 10.3390/molecules25092224.
9
Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1α-NRF-1 and IRS1-AKT-GLUT2 signaling pathways.脱氢表雄酮通过激活 AMPK-PGC-1α-NRF-1 和 IRS1-AKT-GLUT2 信号通路来防止高脂肪诱导的肝糖脂代谢紊乱和胰岛素抵抗。
Int J Obes (Lond). 2020 May;44(5):1075-1086. doi: 10.1038/s41366-019-0508-8. Epub 2020 Jan 7.
10
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date.糖尿病性心肌病:病理生理学、理论及迄今的证据
World J Diabetes. 2019 Oct 15;10(10):490-510. doi: 10.4239/wjd.v10.i10.490.